iDose TR Administration in an Office-Based Surgery Setting
Recruiting · NCT07816692 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
iDose TR (travoprost intracameral implant) 75 µg
What this trial is about
Clinical in-use observational trial to evaluate the administration of iDose TR (travoprost intracameral implant) in an office-based surgery setting.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Diagnosis of Open angle glaucoma (OAG) or ocular hypertension (OHT)
Exclusion criteria
- Prior administration of iDose TR or administration of an investigational intracameral implant in the study eye Active ocular infection or inflammation History of hypersensitivity to travoprost or implant components Recent ocular surgery Uncontrolled systemic disease Any condition preventing safe implantation
Where it is running
1 location listed across 1 US state.
- Glaukos Investigative Site - Austin, Texas, United States